1Life Healthcare, Inc.
ONEMNASDAQHealthcare
$16.47
+$0.00(+0.00%)
Market Cap$3.4B
P/E Ratio—
52W High$17.55
52W Low$5.94
1Life Healthcare, Inc. (ONEM) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ONEM · earnings · updated Jun 8, 2026
Latest Earnings
Q1 FY2023Report Date: Feb 21, 2023EPS Actual
-$0.49
Est. -$0.53 · +7.5%
Revenue
—
Est. $0.31B
Fiscal Period
Q1 FY2023
FY ends December
Report Date
Feb 21, 2023
After Market Close
▲ Beat EPS✓ 1-Quarter EPS Beat Streak
ONEM reports quarterly as a NASDAQ-listed Medical - Healthcare Information Services company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ▲ Q1 FY2023 | Feb 21, 2023 | -$0.53 | -$0.49 | +7.5% | — | $0.31B | — |
| — Q4 FY2022 | Dec 31, 2022 | — | -$0.49 | — | $0.27B | — | — |
| ▼ Q4 FY2022 | Nov 2, 2022 | -$0.46 | -$0.57 | -23.9% | $0.26B | — | — |
| — Q3 FY2022 | Aug 3, 2022 | -$0.48 | -$0.48 | +0.0% | $0.26B | — | — |
| ▲ Q2 FY2022 | May 4, 2022 | -$0.49 | -$0.47 | +4.1% | $0.25B | $0.25B | +2.5% |
| — Q4 FY2021 | Dec 31, 2021 | — | -$0.50 | — | $0.23B | — | — |
| ▼ Q4 FY2021 | Nov 3, 2021 | -$0.26 | -$0.51 | -96.2% | $0.15B | $0.12B | +29.1% |
| ▼ Q3 FY2021 | Aug 4, 2021 | -$0.20 | -$0.30 | -50.0% | $0.12B | $0.12B | +0.0% |
Q1 FY2023
Feb 21, 2023Beat
EPS Actual
-$0.49
EPS Est.
-$0.53
EPS Surpr.
+7.5%
Revenue
—
Q4 FY2022
Dec 31, 2022
EPS Actual
-$0.49
EPS Est.
—
EPS Surpr.
—
Revenue
$0.27B
Q4 FY2022
Nov 2, 2022Miss
EPS Actual
-$0.57
EPS Est.
-$0.46
EPS Surpr.
-23.9%
Revenue
$0.26B
Q3 FY2022
Aug 3, 2022
EPS Actual
-$0.48
EPS Est.
-$0.48
EPS Surpr.
+0.0%
Revenue
$0.26B
Q2 FY2022
May 4, 2022Beat
EPS Actual
-$0.47
EPS Est.
-$0.49
EPS Surpr.
+4.1%
Revenue
$0.25B
Q4 FY2021
Dec 31, 2021
EPS Actual
-$0.50
EPS Est.
—
EPS Surpr.
—
Revenue
$0.23B
Q4 FY2021
Nov 3, 2021Miss
EPS Actual
-$0.51
EPS Est.
-$0.26
EPS Surpr.
-96.2%
Revenue
$0.15B
Q3 FY2021
Aug 4, 2021Miss
EPS Actual
-$0.30
EPS Est.
-$0.20
EPS Surpr.
-50.0%
Revenue
$0.12B
No analyst estimates available for ONEM.
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q1 FY2023 | Feb 21, 2023 | +7.5% | $16.01 | $16.47 | +2.87% |
| — Q4 FY2022 | Dec 31, 2022 | — | $16.71 | $16.58 | -0.78% |
| ▼ Q4 FY2022 | Nov 2, 2022 | -23.9% | $17.09 | $16.97 | -0.70% |
| ▲ Q3 FY2022 | Aug 3, 2022 | +0.0% | $16.98 | $17.10 | +0.71% |
| ▲ Q2 FY2022 | May 4, 2022 | +4.1% | $7.42 | $7.83 | +5.53% |
| — Q4 FY2021 | Dec 31, 2021 | — | $17.36 | $17.57 | +1.21% |
| ▼ Q4 FY2021 | Nov 3, 2021 | -96.2% | $21.41 | $21.52 | +0.51% |
| ▼ Q3 FY2021 | Aug 4, 2021 | -50.0% | $27.88 | $27.94 | +0.22% |
Q1 FY2023+2.87%
Report Date
Feb 21, 2023
EPS Beat/Miss
+7.5%
Price Before
$16.01
Price After
$16.47
Q4 FY2022-0.78%
Report Date
Dec 31, 2022
EPS Beat/Miss
—
Price Before
$16.71
Price After
$16.58
Q4 FY2022-0.70%
Report Date
Nov 2, 2022
EPS Beat/Miss
-23.9%
Price Before
$17.09
Price After
$16.97
Q3 FY2022+0.71%
Report Date
Aug 3, 2022
EPS Beat/Miss
+0.0%
Price Before
$16.98
Price After
$17.10
Q2 FY2022+5.53%
Report Date
May 4, 2022
EPS Beat/Miss
+4.1%
Price Before
$7.42
Price After
$7.83
Q4 FY2021+1.21%
Report Date
Dec 31, 2021
EPS Beat/Miss
—
Price Before
$17.36
Price After
$17.57
Q4 FY2021+0.51%
Report Date
Nov 3, 2021
EPS Beat/Miss
-96.2%
Price Before
$21.41
Price After
$21.52
Q3 FY2021+0.22%
Report Date
Aug 4, 2021
EPS Beat/Miss
-50.0%
Price Before
$27.88
Price After
$27.94
Avg Beat Reaction+3.04%
Avg Miss Reaction+0.01%
Beat Rate3 / 8 quarters
Largest Move+5.53% (Q2 FY2022)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ONEM ends December
1Life Healthcare, Inc. (ONEM) most recently reported earnings on February 21, 2023 for Q1 FY2023, posting EPS of $-0.49 — beating the analyst consensus of $-0.53 by +7.5%. The next ONEM earnings date is expected around September 1, 2026.
Each quarter, investors track ONEM earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ONEM revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ONEM's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ONEM earnings · 5 questions1Life Healthcare, Inc.'s next earnings report is expected around September 1, 2026. ONEM typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ONEM historically reports after market close (AMC).
ONEM earnings datewhen is ONEM earningsONEM next earnings datewhen does ONEM report earningsONEM earnings calendar
▸ Source: FMP · 1Life Healthcare, Inc. SEC filings · US GAAP · 1Life Healthcare, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026